Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy

Cardiovascular Drugs and Therapy

Volumn 13, Issue 3, 1999, Pages 259-264

  Petkow Dimitrow, Paweł ^a   Krzanowski, Marek ^a   Niz̀ankowski, Rafal ^a   Szczeklik, Andrzej ^a   Dubiel, Jacek Stefan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Endothelium dependent vasodilatation; Hypertrophic cardiomyopathy; Verapamil

Indexed keywords

VERAPAMIL;

ADULT; AORTA PRESSURE; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY VASCULAR RESISTANCE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; BLOOD FLOW VELOCITY; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHY, HYPERTROPHIC; COLD; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; VASCULAR RESISTANCE; VASODILATION; VASOMOTOR SYSTEM; VERAPAMIL;

EID: 0033001178     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007704427719     Document Type: Article

References (36)

1. 1. Kodama K, Hamada M, Kazatani Y, et al. Clinical characteristics in Japanese patients with coexistent hypertrophic cardiomyopathy and coronary vasospasm. Angiology 1998; 49:849-855.
2. 2. Iida H, Fujii T, Miura T, Yoshitake S, Kawamura A, Fujii A. Assessment of endothelium dependent coronary vasodilation in hypertrophic cardiomyopathy, (abstr). Circulation 1996;94:I502.
3. 3. Petkow Dimitrow P, Surdacki A, Dubiel JS. Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drug Ther 1997;11:741-746.
4. 4. Nabel EG, Ganz P, Gordon JB, Alexader RW, Selwyn AP. Dilatation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988;77:43-52.
5. 5. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
6. 6. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-1992.
7. 7. Takase H, Moreau P, Kung Ch, Nava E, Luscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency, effect of verapamil and trandolapril. Hypertension 1996;27:25-31.
8. 8. Dagenais F, Cartier R, Hollmann C, Buluran J. Calcium-channel blockers preserve endothelial reactivity after ischemia-reperfusion. Ann Thorac Surg 1997;63:1050-1056.
9. 9. Hozumi T, Yoshida K, Ogata Y, et al. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97:1557-1562.
10. 10. Crowley JJ, Dardas PS, Harcombe AA, Shapiro LM. Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy. Heart 1997;77:558-563.
11. 11. Report of World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93: 841-842.
12. 12. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43: 1242-1244.
13. 13. Ishihara M, Sato H, Tateishi H, et al. Effects of various doses of intracoronary verapamil on coronary resistance vessels in humans. Jpn Circ J 1997;61:755-761.
14. 14. Antony G, Nitenberg A, Foult J-M, Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993;22:514-520.
15. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-2542.
16. 16. Udelson JE, Bonow RO, O'Gara PT, et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1989;79:1052-1060.
17. 17. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-2352.
18. 18. Kaufman Ph, Vassalli G, Seiler Ch, Hess OM. Abnormal coronary vasomotion in hypercholesterolemia: Reversibility by calcium antagonists. Eur Heart J 1994;15(Abstract Suppl.):330.
19. 19. Frielingsdorf J, Kaufmann Ph, Seiler Ch, Vassali G, Suter T, Hess OM. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation 1996;93:1380-1387.
20. 20. Dubois-Rande JL, Dupouy P, Aptecar E, et al. Comparison of the effects of exercise and cold pressor test on the vasomotor response of normal and atherosclerotic coronary arteries and their relation to the flow-mediated mechanism. Am J Cardiol 1995;76:467-473.
21. 21. Ismail Y, Abdelmessih NK, Wong I, et al. Effect of nitric oxide synthesis inhibition on the coronary sinus blood flow response to the cold pressor test: Evaluation by transthoracic echocardiography (abstr). Circulation 1996;94:I592.
22. 22. Maron BJ, Wolfson JK, Epstein SE. Intramural ("small vessel") coronary disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-547.
23. 23. Suzuki H, Koba S, Katagiri T, Takeyama Y, Suwa Y. Ultrastructural changes of blood capillaries in patients with microvascular angina, hypertrophic cardiomyopathy, and dilated cardiomyopathy. Am J Cardiovasc Pathol 1995;5: 19-26.
24. 24. Takemura G, Takatsu Y, Fujiwara H. Luminal narrowing of coronary capillaries in human hypertrophic hearts: An ultrastructural morphometrical study using endomyocardial biopsy specimens. Heart 1998;79:78-85.
25. 25. Simonetti I, Trivella MG, Michaelassi C, Parodi O, De Nes DM, L' Abbate A. Dose-response scrutiny of coronary vasodilation after intracoronary verapamil in man. A quantitative cineangiographic study. Eur Heart J 1986;7:848-858.
26. 26. Chew Ch, Brown G, Singh BN, Wong MM, Pierce C, Petersen R. Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action. Am J Cardiol 1983;51:699-705.
27. 27. Shibata K, Hirasawa A, Foglar R, Ogawa S, Tsujimoto G. Effects of quinide and verapamil on human cardiovascular alpha 1-adrenoceptors. Circulation 1998;97:1227-1230.
28. 28. Bronztti E, Felici L, Polidori C, Amenta F. Interactions between calcium channel blockers and alpha-adrenoceptors in the human coronary and mammary arteries: A radioligand binding study. J Auton Pharmacol 1994;14:79-85.
29. 29. Novosel D, Lang MG, Noll G, Luscher TF. Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat; effects of therapy with verapamil and trandolapril alone and in combination. J Cardiovascular Pharmacol 1994;24:979-985.
30. 30. Vita JA, Treasure ChB, Yeung AC, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sen sitivity to constrictor effects of catecholamines. Circulation 1992;85:1390-1397.
31. 31. Bassenge E, Stewart DJ. Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy. Cardiovasc Drugs Ther 1988;1: 47-55.
32. 32. Dohi Y, Criscione L, Pfeiffer K, Luscher TF. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: Studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994;24: 372-379.
33. 33. Ritz MA, Luscher TF. Different potencies of endothelium-derived relaxing factors against thromboxane and endothelin-1 in coronary arteries: Comparison with nitrovasodilator and calcium antagonists. Cor Art Dis 1991;2: 1001-1008.
34. 34. Raymenants E, Yang B, Nicolini F, Berhrens P, Lawson D, Mehta JL. Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact or disrupted endothelium. J Am Coll Cardiol 1993;22:684-689.
35. 35. Wilson RF, Laughlin DE, Ackell PH, et al. Transluminal subselective measurement of coronary artery flow velocity and vasodilator reserve in man. Circulation 1985;72:82-92.
36. 36. Bartel T, Baumgart S, Muller S, Haude M, Erbel R. Validation of transthoracic Doppler measurements of coronary flow velocity by intracoronary Doppler guidewire (abstr). J Am Coll Cardiol 1998;31(Suppl. C):243C.